Dr. Cascone on Combination Checkpoint Blockade for Early-Stage Non–Small-Cell Lung Cancer

June 7, 2019

Cancer Network spoke with Tina Cascone, MD, of MD Anderson Cancer Center, at ASCO 2019 about combination checkpoint blockade in the pre-surgical setting for early-stage NSCLC.

Cancer Network spoke with Tina Cascone, MD, an oncologist and assistant professor of Thoracic/Head & Neck Medical Oncology at MD Anderson Cancer Center, about the combination checkpoint blockade effective in the pre-surgical setting for early-stage non–small-cell lung cancer. The results of the study (abstract 8504) were presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.